Skip to main content

Table 3 Adverse drug reaction reporting practice among the health workers

From: Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria

Variable

Frequency (%)

Ever encounter adverse drug reaction (ADR) at health facility (n = 80)

 Yes

47 (58.8)

 No

33 (41.2)

Measure(s) taken in the case of encountered ADRs (n = 92)a

 Refer to a secondary health facility

50 (54.3)

 Treat symptoms with another drug

30 (32.6)

 Provide counselling to patients

7 (7.6)

 Stop the use of the drug

5 (5.4)

Ever come across ADR reporting form (n = 80)

 Yes

30 (37.5)

 No

50 (62.5)

Is ADR reporting form available in your facility? (n = 80)

 Yes

17 (21.3)

 No

63 (78.8)

Barrier(s) in obtaining the ADR reporting form (n = 17)

 No known source of obtaining the form

9 (5.3)

 No proper distribution of form

4 (2.4)

 Not the duty of primary healthcare

4 (2.4)

Who should report ADRs? (n = 91)a

 Any healthcare worker

50 (71.4)

 Patients

26 (28.6)

 Only senior healthcare worker

15 (16.5)

Ever received training on pharmacovigilance and/or ADR reporting? (n = 80)

 Yes

11 (13,8)

 No

69 (86.2)

Opinion on willingness to receive training (n = 80)

 Yes

73 (91.2)

 No

7 (8.8)

Self-rating score on interest to undergo training in pharmacovigilance (n = 73)

 < 5

0 (0.0)

 5–7

8 (11.0)

 8–10

65 (89.0)

Reasons for the interest to undergo pharmacovigilance training (n = 80)

 Acquire more knowledge on ADRs and reporting

56 (70.0)

 Know more about the detection, assessment and prevention of ADRs

15 (18.7)

 Patient care and safety

4 (5.0)

 Easy access to ADR reports and early treatment of ADRs

3 (3.8)

 More knowledge on ADRs, especially on how to fill the form

2 (2.5)

Regulatory bodies responsible for monitoring ADRs (n = 138)a

 NAFDAC

46 (33.3)

 PCN

35 (25.4)

 FMOH

30 (21.7)

 WHO

27 (19.6)

  1. NAFDAC National Agency for Food and Drug Administration and Control, PCN Pharmacists Council of Nigeria, WHO World Health Organisation, FMOH Federal Ministry of Health, ADR Adverse Drug Reaction
  2. aMultiple response